α-Synuclein (34-45) peptide

Small-molecule and peptide inhibitors of m6A regulators

Published Time: 2025-08-01

About us

About us

• Who we are
  • Mission and values
  • History
  • Leadership
  • Awards
• Impact and progress
  • Frontiers' impact
  • Our annual reports
  • Thought leadership
• Publishing model
  • How we publish
  • Open access
  • Peer review
  • Research integrity
  • Research Topics
  • FAIR² Data Management
  • Fee policy
• Services
  • Societies
  • National consortia
  • Institutional partnerships
  • Collaborators
• More from Frontiers
  • Frontiers Forum
  • Frontiers Planet Prize
  • Press office
  • Sustainability
  • Career opportunities
  • Contact us

Sections

Sections

• Breast Cancer
• Cancer Cell Signaling
• Cancer Epidemiology and Prevention
• Cancer Genetics
• Cancer Imaging and Image-directed Interventions
• Cancer Immunity and Immunotherapy
• Cancer Metabolism
• Cancer Molecular Targets and Therapeutics
• Cardio-Oncology
• Gastrointestinal Cancers: Colorectal Cancer
• Gastrointestinal Cancers: Gastric and Esophageal Cancers
• Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
• Genitourinary Oncology
• Gynecological Oncology
• Head and Neck Cancer
• Hematologic Malignancies
• Molecular and Cellular Oncology
• Neuro-Oncology and Neurosurgical Oncology
• Pediatric Oncology
• Pharmacology of Anti-Cancer Drugs
• Radiation Oncology
• Skin Cancer
• Surgical Oncology
• Thoracic Oncology

About journal

About journal

• Scope
  • Field chief editors
  • Mission & scope
  • Facts
  • Journal sections
  • Open access statement
  • Copyright statement
  • Quality
• For authors
  • Why submit?
  • Article types
  • Author guidelines
  • Editor guidelines
  • Publishing fees
  • Submission checklist
  • Contact editorial office